NCT00775736
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Brussels, Belgium
- Novo Nordisk Investigational Site Luxembourg
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00097279
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Glendale, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Searcy, Arkansas, United States
NCT01475734
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- GSK Investigational Site Chula Vista, California, United States
NCT00598793
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Walnut Creek, California, United States
- Novo Nordisk Investigational Site Melbourne, Florida, United States
NCT01536639
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Bratislava, Slovakia
NCT01357889
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Dothan, Alabama, United States
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Hallandale, Florida, United States
NCT00849017
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Alabaster, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Dothan, Alabama, United States
NCT00657319
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Budapest, Hungary
NCT00838903
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Dothan, Alabama, United States
- GSK Investigational Site Hueytown, Alabama, United States
Completed
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
NCT00839527
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Alabaster, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States